EPISODE · Mar 3, 2026 · 1H 5M
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
from The Long Run with Luke Timmerman · host Timmerman Report
Ken Song, CEO of San Diego-based Candid Therapeutics, on developing bispecific T-cell engaging antibodies for autoimmune disease.
Embed this episode
NOW PLAYING
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
0:00
1:05:45
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Long Run with Luke Timmerman?
This episode is 1 hour and 5 minutes long.
When was this The Long Run with Luke Timmerman episode published?
This episode was published on March 3, 2026.
Can I download this The Long Run with Luke Timmerman episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!